Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares [Yahoo! Finance]
Stoke Therapeutics, Inc. (STOK)
Last stoke therapeutics, inc. earnings: 11/12 08:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
sale of 4,355 shares of Common Stock for a transaction value of approximately $174,000 on March 10, 2026, according to a SEC Form 4 filing Transaction summary Metric Value Shares sold (direct) Transaction value ~$174,000 Post-transaction common shares (direct) Post-transaction value (direct ownership) ~$1.20 million Transaction value based on SEC Form 4 weighted average purchase price ($40.00); post-transaction value based on March 10, 2026 market close price. Key questions What prompted the share sale, and how does the derivative context affect its interpretation? The transaction resulted from the exercise of 3,955 stock options, immediately followed by a sale, indicating a liquidity event tied to equity compensation rather than an open-market reduction in long-held equity. How did the transaction impact Arthur Tzianabos's ownership position? The sale reduced his direct Common Stock holdings by 12.20%, to 31,339 shares; however, he continues to hold 118,
Show less
Read more
Impact Snapshot
Event Time:
STOK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STOK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STOK alerts
High impacting Stoke Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
STOK
News
- Stoke Therapeutics CMO Sells $457,000 in Stock Amid 300% Rally [Yahoo! Finance]Yahoo! Finance
- Stoke Therapeutics (STOK) had its price target raised by Canaccord Genuity Group Inc. from $36.00 to $60.00. They now have a "buy" rating on the stock.MarketBeat
- Stoke Therapeutics (STOK) had its "buy" rating reaffirmed by BTIG Research. They now have a $39.00 price target on the stock.MarketBeat
- Stoke Therapeutics (STOK) had its "buy" rating reaffirmed by Chardan Capital. They now have a $35.00 price target on the stock.MarketBeat
- Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)Business Wire
STOK
Earnings
- 3/16/26 - Beat
STOK
Sec Filings
- 3/27/26 - Form 8-K
- 3/27/26 - Form SCHEDULE
- 3/24/26 - Form 4
- STOK's page on the SEC website